Skip to main content

CV Sciences, Inc.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

CVSIStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

Nine Months Ended September 30,
20252024
OPERATING ACTIVITIES
Net loss$(752)$(1,668)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation and amortization171220
Stock-based compensation374154
Amortization of debt discount386117
Amortization of right of use assets17586
Gain on debt extinguishment(38)—
Benefit from reversal of accrued payroll tax (Note 12)(522)—
Gain in fair value of contingent consideration liabilities—(188)
Other128236
Change in operating assets and liabilities:
Accounts receivable, net13019
Inventory830689
Prepaid expenses and other141208
Accounts payable and accrued expenses(1,076)(570)
Net cash flows used in operating activities(53)(697)
INVESTING ACTIVITIES
Purchases of property and equipment(100)—
Acquisition of business, net of cash acquired—(6)
Net cash flows used in investing activities(100)(6)
FINANCING ACTIVITIES
Proceeds from note payable1,200900
Debt issuance costs related to note payable(82)(5)
Repayment of note payable(900)(325)
Repayment of unsecured debt(139)(203)
Net cash flows provided by financing activities79367
Effect of exchange rate changes on cash1(2)
Net decrease in cash(73)(338)
Cash, beginning of period4541,317
Cash, end of period$381$979
Supplemental cash flow disclosure:
Interest paid$4$6
Income taxes paid$7$6
Supplemental disclosures of non-cash transactions:
Services paid with common stock$60$92
Right of use asset financed by lease liabilities$486$—
Original issuance discount for note payable$(400)$(284)
Debt modification cost$(150)$—
Working capital adjustment due from seller$—$34
Fair value of net assets acquired, excluding cash$—$341
Goodwill on acquisition$—$365
Common stock consideration$—$(700)
Cash paid for acquisition$—$6
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.